PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.4913
+0.0106 (2.21%)
At close: Sep 3, 2026, 4:00 PM EDT
0.5000
+0.0087 (1.77%)
Pre-market: Sep 4, 2026, 8:37 AM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $5.27 million as of September 3, 2026. Its market cap has decreased by -16.28% in one year.
Market Cap
5.27M
Enterprise Value
-31.81M
1-Year Change
-16.28%
Ranking
Category
Stock Price
$0.49
ChartMarket Cap Chart
Since August 10, 2021, PharmaCyte Biotech's market cap has increased from $4.90M to $5.27M, an increase of 7.64%. That is a compound annual growth rate of 1.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 5.30M | -27.40% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 957.14% |
| Aug 10, 2021 | 4.90M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 5.99M |
| Processa Pharmaceuticals | 5.87M |
| Can-Fite BioPharma | 5.73M |
| Cardio Diagnostics Holdings | 5.45M |
| Pulmatrix | 5.37M |
| Kairos Pharma | 5.35M |
| Liminatus Pharma | 5.16M |
| Dermata Therapeutics | 5.15M |